Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Biomed Res Int ; 2015: 282301, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26247014

RESUMEN

OBJECTIVE: To compare pregnancy rate after controlled ovarian hyperstimulation and intrauterine insemination (COH-IUI) with no treatment in patients with endometriosis-associated infertility treated with laparoscopy. DESIGN: A clinical cohort study. SETTING: University-level tertiary care center. PATIENTS: 238 women with various stages of endometriosis after laparoscopic treatment. INTERVENTIONS: Either COH-IUI or follow-up for 12 months. MAIN OUTCOME MEASURES: The primary outcome measures were clinical pregnancy and live birth rate. Predictive factors evaluated were female age, maternal BMI, and duration of infertility. RESULTS: The pregnancy rate attained after the integrated laparoscopy-COH-IUI approach was 53.4%, while it was significantly lower (38.5%) in the control group. Similarly, a significant difference was observed in live births (48.3% versus 34.2%). Patients with severe endometriosis were less likely to achieve pregnancy (38%) and live birth (35%) than their counterparts with milder forms (57% and 53%). CONCLUSIONS: In patients with endometriosis-based infertility, surgery followed by COH-IUI is more effective than surgery alone.


Asunto(s)
Endometriosis/epidemiología , Endometriosis/cirugía , Infertilidad/prevención & control , Inseminación Artificial/estadística & datos numéricos , Inducción de la Ovulación/estadística & datos numéricos , Índice de Embarazo , Adulto , Distribución por Edad , Estudios de Cohortes , Terapia Combinada/estadística & datos numéricos , Comorbilidad , Femenino , Humanos , Hungría/epidemiología , Infertilidad/epidemiología , Laparoscopía/estadística & datos numéricos , Nacimiento Vivo/epidemiología , Embarazo , Prevalencia , Factores de Riesgo , Resultado del Tratamiento
2.
Magnes Res ; 16(2): 131-6, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12892384

RESUMEN

A randomized, placebo-controlled clinical pilot study was performed in order to examine the effect of magnesium-orotate in male idiopathic infertility. Ten males were treated daily for 90 consecutive days with 3000 mg magnesium-orotate (Magnerot) tablets (Group M). As a control, ten other males were treated in the same way with placebo (Group P). Conventional microscopic sperm characteristics (sperm concentration, motility ratio, total number of motile sperm cells, normal morphology ratio), plus total and ionized magnesium levels in seminal plasma and blood serum were evaluated both prior to treatment and on day 90, at the conclusion of the study. No significant changes in sperm characteristics, blood ionized or total Mg, or ejaculate total Mg levels were detected. However, ejaculate ionized Mg levels increased in Group M from 0.18 +/- 0.05 to 0.30 +/- 0.05 (mmol/l; mean +/- SD, p < 0.05). Within the observation period of 3 months, one pregnancy occurred in the partner of a male from Group M. In conclusion, magnesium-orotate treatment at a dose of 3000 mg/day leads neither to a significant improvement of sperm variables nor does it increase the pregnancy rates of female partners of treated males as compared to those of controls. Thus, magnesium-orotate treatment was not shown to be effective therapy for idiopathic male infertility.


Asunto(s)
Suplementos Dietéticos , Infertilidad Masculina/tratamiento farmacológico , Magnesio/uso terapéutico , Ácido Orótico/uso terapéutico , Adulto , Femenino , Humanos , Magnesio/sangre , Magnesio/metabolismo , Masculino , Proyectos Piloto , Placebos , Embarazo , Índice de Embarazo , Semen/metabolismo , Motilidad Espermática , Espermatozoides/patología , Factores de Tiempo
3.
Acta Obstet Gynecol Scand ; 85(8): 993-6, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16862481

RESUMEN

BACKGROUND: Infertile Hungarian couples were surveyed with regard to their opinion of preconception gender selection by the separation of X- and Y-bearing sperm populations. METHODS: Self-completion of a questionnaire. Group 1: subjects presenting for infertility examination; Group 2: presenting for homologous intrauterine insemination. RESULTS: As concerns the gender of the firstborn, 13.8% of those in Group 1 preferred a boy and 10.3% a girl, while 75.9% had no preference. The male preference was higher in Group 2: 33.3% preferred a boy and 7.4% a girl while 59.3% had no preference (chi 2, p < 0.05). In the event of a wish for more offspring, 91% in Group 1 and 94% in Group 2 did not have a wish for only one particular gender. In Group 2, 30.8% were willing to pay the extra costs for a gender selection procedure as compared with only 10.8% of the couples in Group 1 (chi 2, p < 0.05). If the National Health Fund fully covered the costs, 53.4% in Group 1 and 38.5% in Group 2 would request the procedure for nonmedical reasons, while 94.6% and 97.4% of them, respectively would so for medical reasons. CONCLUSIONS: Our findings revealed a trend to preference for firstborn males, although couples wishing more than one offspring prefer equal numbers of male and female children. The utilization of preconception gender selection, therefore, would not seem to appreciably affect the natural male/female ratio. Genetic indications exert significant effects on the decision regarding sex selection procedures.


Asunto(s)
Orden de Nacimiento/psicología , Infertilidad/psicología , Inseminación Artificial Homóloga/psicología , Preselección del Sexo/psicología , Adulto , Composición Familiar , Femenino , Humanos , Hungría , Masculino , Encuestas y Cuestionarios
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA